Meeting
2016 ASCO Annual Meeting
Derivation of gene expression classifiers for the non-invasive detection of bladder cancer in the hematuria and recurrence surveillance populations.
Authors
Karen B. Chapman
OncoCyte Corporation, Alameda, CA
Karen B. Chapman , Ljubomir Buturovic , Liqun Qiu , Jennifer Kidd , Nadia Sheibani , Damjan Krstajic , Lyssa Friedman , James L. Bailen , Igor Dumbadze , Daniel R. Saltzstein , Matthew T. Olson , Neal D. Shore
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Molecular Diagnostics and Imaging
Citation
J Clin Oncol 34, 2016 (suppl; abstr 11522)
DOI
10.1200/JCO.2016.34.15_suppl.11522
Abstract #
11522
Poster Bd #
219
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Novel platform for monitoring bladder cancer recurrence using expression analysis of small non-coding RNAs.
First Author: Ilija Aleksic
Poster
2023 ASCO Annual Meeting
An in-progress phase 2 window of opportunity (WOO) trial of targeted therapy with erdafitinib for patients with recurrent FGFR3-altered non–muscle-invasive bladder cancer (NMIBC).
First Author: Neeta DSouza
Poster
2023 ASCO Genitourinary Cancers Symposium
Complimentary genomic, pathologic, and artificial intelligence analysis on low-grade noninvasive bladder cancer to predict downstream recurrence.
First Author: Kyle M. Rose
Poster
2022 ASCO Genitourinary Cancers Symposium
Management, surveillance patterns, and costs associated with low-grade papillary (Ta) nonmuscle-invasive bladder cancer.
First Author: Kelly K. Bree